1985 Volume 32 Issue 5 Pages 745-751
In 10 euthyroid subjects a single 2.5mg per os dose of bromocriptine caused rapid and remarkable decreases in serum TSH. As much as a 0.85±0.18 (s.d.)μU/ml decrease from the basal level (56±9%) was observed at 5 hours.A good correlation was observed between the basal TSH level and the TSH decrease after bromocriptine (r=0.786).
In 4 patients taking 5 to 15mg bromocriptine daily (chronic administration group), another 2.5mg bromocriptine also caused significant decreases in serum TSH, but the degree (0.42±0.03μU/ml, 43±26% of basal) and duration (maximal at 4 hours) were less than those observed in the untreated group. The lowest TSH levels in these two groups did not differ significantly (0.80±0.45 and 0.78±0.53μU/ml, respectively).
The TSH decrease after bromocriptine in the untreated group was found not to correlate significantly with TRH induced TSH increase (r=0.300). TRH induced TSH increase in the chronic administration group was similar to or greater than that of control subjects with matched basal TSH.
The TSH lowering effects of per os prednisolone and triiodothyronine were also studied. Prednisolone exerted a quite similar effect to bromocriptine, but a certain time lag was observed in the case of triiodothyronine.
A single dose of bromocriptine was found to lower serum TSH levels even in euthyroid subjects. The effect was considered to be independent of TRHTSH regulation and to act directly on the TSH release.
